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Abstract  
 
Depression is often a risk factor for cardiovascular disease, and psychotherapy for depression can 
result in positive cardiovascular disease outcomes for patients. A correlational study explored the 
impact of psychotherapy referrals with medication treatment for depression on cardiovascular 
risk factors of blood pressures, HbA1C, and depression which is measured by the Patient Health 
Questionnaire (PHQ-9). At three internal medicine clinics in the Midwest, 31 adults with 
depression and cardiovascular risk factors were included in the psychotherapy intervention. 
Retrospective data was collected from August 2015-August 2016 prior to the psychotherapy 
referrals, and prospective data was obtained from September 2016-December 2016 from clients 
receiving psychotherapy referrals with medication treatment which was initiated for patients with 
a diagnosis of depression and cardiovascular risk factors. Pre-post risk factors of blood pressure, 
HbA1C, and depression were measured within the intervention group. The project found a strong 
positive correlation between HbA1C and PHQ-9 with psychotherapy but no significant 
correlation between blood pressures and PHQ-9 scores in the intervention group. Regression 
analysis confirmed that depression treatment positively affects HbA1C and PHQ-9 scores. 
Treatment of depression can reduce cardiovascular risk factors and favorably impact mortality 
and morbidity 
Keywords: Cardiovascular, depression, disease, intervention, outcomes, relationship  
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Psychotherapeutic Interventions for Depression Reducing Cardiovascular Disease Risk in Adults  
Depression and cardiovascular disease (CVD) associations have been well established 
and even considered bidirectional in adults (Baune et al., 2012; Nemeroff & Goldschmidt-
Clermont, 2012). In a representative U.S. sample, mood disorders were found to have an 
increased risk of heart disease which is independent of age, geographic location, education, 
income, race, marital status, employment, smoking, obesity, history of heart disease in family, 
hypertension, and diabetes (Fiedorowicz, 2014). Furthermore, in developed countries, CVD and 
depression have recently presented as the two most common causes of disability, and other 
countries are expected to have the same outcome by 2030 (Hare, Toukhsati, Johansson, & 
Jaarsma, 2014). Depression alone can increase the risk of CVD up to 1.5 times in adults, and 
adults with coronary artery disease and depression are two to three times more likely to face risk 
of non-fatal and fatal cardiac events in the future as compared to adults with coronary artery 
disease without depression (Baune et al., 2012). 
Cardiovascular disease is a significant cause of mortality and reduction in quality of life 
worldwide (Heijmans, van Lieshout, & Wensing, 2014). According to the U.S. Department of 
Health and Human Services (DHHS, 2016), the number of adults living with multiple types of 
CVD is now greater than 1 in 3, or about 81.1 million. In 2010, more than $500 billion was spent 
on cardiovascular disease in adults in the United States (U.S. Department of Health and Human 
Services, 2016). Locally, heart disease mortality rate in Metro Midwest city is significant. As 
reported by the Kansas Department of Health and Environment (KDHE), for every 100,000 
population, approximately132 adult deaths are related to CVD (KDHE, 2012). The statistics 
include all ethnicities. Recently, the American Heart Association (AHA, 2013) places Kansas as 
the 26th highest death rate from cardiovascular disease in the country and also reports heart 
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disease to be the second highest cause of death in Kansas. The goal of DHHS (2016), Healthy 
People 2020, is to improve health and quality of life for cardiovascular patients using a three-
pronged approach: prevent and detect risk factors for heart attack and stroke, identify and treat 
heart attacks and strokes as early as possible, and prevent repeat cardiovascular events.  
Assessment and communication of lifetime risk for cardiovascular disease have become more 
prominent issues in cardiovascular health (DHHS, 2016). This project site is in Overland Park, 
Kansas, and the population identifies as Caucasian (78.8%), Asian (6.6%), Hispanic (6.0%), and 
African American (5.7%). This diverse population belongs to several ethnicities including Indian 
Asians and non-Hispanic Caucasian. However, patients from surrounding suburban areas also 
seek care at the internal medicine clinic. 
Depression is a common disorder among adults. The National Comorbidity Study, the 
largest study of psychiatric disorders, reported that major depressive disorder (MDD) has a 
lifetime prevalence of 16.6% (Nemeroff & Goldschmidt-Clermont, 2012). A recent scientific 
statement by AHA concludes that acute coronary syndrome followed by depression is a risk 
factor for all-cause and cardiac mortality in adults, as well as for combined outcomes including 
mortality or nonfatal cardiac events (Fiedorowicz, 2014). Furthermore, depression also predicts 
poor outcomes following hospitalization for cardiovascular events (Bradley & Rumsfeld, 2015). 
In addition to an association with poorer survival rates, depression is also strongly associated 
with worse patient health status such as symptom affliction, functionality, and quality of life 
(Bradley & Rumsfeld, 2015). It is imperative to understand the effect of depression on 
cardiovascular disease in primary care, where the interventions can be provided early and 
possibly avert the catastrophic effect of depression. Hence, this evidenced based project focuses 
on reduction of cardiovascular risk factors of blood pressure, HbA1C, and depression as 
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measured by the Patient Health Questionnaire (PHQ-9) in the adult population with 
psychotherapeutic intervention for depression in the Midwest Metro City area. 
Problem Statement  
CVD and depression are the leading cause of health and economic problems across the 
world (O’Neil, Williams, Stevenson, Oldenburg, & Sanderson, 2012). CVD is a leading cause of 
death while depression is most commonly associated with disability (O’Neil et al., 2011). 
Etiological and extrapolative studies denote that depression and CVD are interlinked and 
mutually influencing; depression can be both a cause or a result of CVD (Möller-Leimkühler, 
2010). Therefore, it is vital to learn about the influence of psychological interventions for 
depression on cardiovascular risk factors to obtain optimum health outcomes for patients.  
Furthermore, there is evidence that also suggests that there may be a cardio-protective 
effect of depression treatment if it is initiated prior to onset of CVD; a study has also suggested 
that the pathogenesis of CVD can have a harmful effect of depression even in an early phase 
(Stewart, Perkins, & Callahan, 2014). Providers’ reluctance to initiate depression treatment is 
also a main factor contributing to the problem of increased cardiovascular health risk (Edward H. 
Wagner, Austin, Davis, Hindmarsh, & al, 2001). Ultimately, a reduction in healthcare cost is an 
important outcome to consider.  
Purpose Statement  
 This DNP project aimed to explore the impact of psychotherapy referrals with or without 
medication treatment for depression on cardiovascular risk factors to promote optimum health 
outcomes for patients.  
Facilitators and Barriers  
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The main facilitators for the project included the Medical Director of Quality Outcomes 
and the Behavioral Health Lead (psychologist) at the internal medicine clinics. Regular meetings 
as well as online dialogue supported communication with the project site professionals to discuss 
implementation issues and computerized information sharing and clinical data. The project site 
professionals recognized a need for change in primary care for patients with depression and the 
leadership was strongly engaged in the processes of the project and was a major facilitator for the 
project. Because the project required minimal cost to the facility and investigators, cost was an 
important facilitator for the evidence based practice (EBP) initiative. 
The internal medicine clinic project sites represented a large organization and achieving 
support from all providers was challenging in order to change treatment strategies. It was 
important to consider that provider buy-in can be influenced by the provider understanding of the 
intervention, especially if there are provider misconceptions about the intervention effectiveness 
or minimal information to the providers. The leadership role was also central in achieving 
positive outcomes for the project, limiting lack of support and accountability from senior 
leadership as a barrier, and sustaining the referral intervention. Timeline constraint was another 
barrier because it presented an outcome in reduction in sample size and consequently resulted in 
skewed outcome. 
Review of Evidence 
PICOT 
In adult patients with a diagnosis of depression and CVD, do psychological interventions 
including psychotherapy with or without psychotherapeutic medications reduce cardiovascular 
risk factors of blood pressure, HbA1C, and depression as measured by PHQ-9 over three months 
to six months at four internal medicine clinics?  
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Search Strategies  
The databases searched and search engines used for ascertaining highly relevant current 
evidence included Cumulative Index to Nursing and Allied Health Literature (CINAHL), 
Cochrane databases, PubMed, Google Scholar, National Guideline Clearinghouse, and 
MEDLINE. Combination of search terms included depression, cardiovascular disease, 
relationship, interventions, and risk factors (see Appendix A for Definition of Terms). Inclusion 
criteria consisted of peer reviewed scholarly journals, evidence-based or research articles, 
English language, and a date range of 2007-2016. Exclusion criteria were articles written in a 
foreign language, research older than 2007, evidence that was not pertinent to the evidence-based 
project, and sources that represented lower levels of evidence. An initial search using the 
identified terms yielded more than 10,000 articles. The search was refined with additional terms 
of randomized control trials, cluster, and retrospective.  
Identified studies were 70, and from those, 30 were pertinent to the evidence-based 
project. Of these research studies, five were applicable to depression and if a relationship with 
cardiovascular diseases exists. Fifteen studies were applicable to the correlation of depression 
and cardiovascular disease and the possible outcomes (see Appendix B). From 150 potential 
guidelines that involved depression and cardiovascular disease, two were identified as most 
relevant to the EBP project.  Prominently, Level I, II, III and IV (Melnyk, 2011) level of 
evidence studies were selected for synthesis of the evidence to support the project.  
Depression and Cardiovascular Disease Risk   
Studies have shown that depression can cause an increased risk of incident of coronary 
artery disease (CAD; Bradley & Rumsfeld, 2015). The relationship between depression and 
CVD is bidirectional (Baune et al., 2012; Nemeroff & Goldschmidt-Clermont, 2012). Practice 
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guidelines state that when screening patients for cardiovascular disease risk among special 
groups such as Asians, Hispanics, and African Americans, attention should be provided to 
patients with depression (National Guideline Clearinghouse, 2009). 
 Deschênesa, Burns, and Schmitz (2015) state that diabetes can make patients more 
susceptible to major depressive disorder (MDD) as well as general anxiety disorder (GAD) 
which can exacerbate disability in diabetic patients (Deschênes et al., 2015). Results also linked 
greater disability to MDD when GAD was not present, to GAD when MDD was not present, and 
to MDD when GAD was present (Deschênes et al., 2015). Chang et al. (2013) conducted a cross-
sectional study which reported that the healthy control group in the study had the highest scores 
for cognitive function, while the group with both late-life depression and cardiovascular disease 
showed the lowest scores for cognitive function impairment. Furthermore, Chang et al. (2015) 
reported that late life depression, compared to cardiovascular comorbidities, has a larger impact 
on worsening cognitive impairment.   
Two longitudinal and case controlled meta-analyses identified that major depressive 
disorder was the most important component that could result in CVD (Van der Kooy et al., 2007; 
Seldenrijk et al., 2015). Additionally, development of CVD is heavily influenced by presence of 
MDD (Van der Kooy et al., 2007). Similarly, in a study conducted by Seldenrijk et al. (2015), 
patients with depressive and anxiety disorders or current depression only were considerably 
linked with increased CVD incidence. Inflammatory markers and depression has also been 
linked together and studies have shown a primary relationship between them (Vaccarino et al., 
2007). Also, early identification and providing prevention and treatment of cardiovascular 
disease are important objectives for patients who have depression and a risk of cardiovascular 
DEPRESSION INTERVENTIONS AND CARDIOVASCULAR DISEASE 9 
disease (Nemeroff & Goldschmidt-Clermont, 2012). In contrast, one study reviewed did not find 
a correlation between depression and cardiovascular disease risk (Wheeler et al., 2012). 
Depression increases cardiovascular risk and is also highly prevalent in patients with 
underlying CVD (Bradley & Rumsfeld, 2015). A meta-analysis conducted by Meijer et al. 
(2011) concluded that post-MI depression could result in a 1 to 3 fold increased risk of impaired 
outcomes within 24 months of MI incidence (Meijer et al., 2011). Additionally, over the past 25 
years, this observed link has been reasonably constant (Meijer et al., 2011). The effect of 
depression with cardiovascular in a work place was explored by O’Neal et al. (2012), and the 
authors concluded that major depressive disorder is linked to a four times increase in decreased 
performance. Also, individuals with major depressive disorder in presence of another chronic 
disease, such as arthritis with CVD, reported increased probability of not being able to work 
(O’Neil et al., 2012). 
Similarly, Almas et al. (2015) conducted a longitudinal cohort study which concluded 
that severity of depression and risk of CVD are directly related, as one increased so did the other 
(Almas, Forsell, Iqbal, Janszky, & Moller, 2015). A cross-sectional randomized control study 
showed that there is a higher rate of occurrence of cardiac risk factors in patients with 
psychological illness (Gardner-Sood et al., 2015).  Rude et al. (2014), in a study with 
hospitalized patients with cardiovascular diseases, concluded that depression is predominant in 
the Hispanic population compared to non-Hispanic. Also, the study found that for this ethnic 
population that depression and duration of stay are closely correlated (Rude et al., 2014). The 
authors state that suitable treatment of depression can reduce duration of stay and hence 
potentially lower costs which ensures a positive impact in health care settings (Rude et al., 2014).  
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The American Heart Association/American Council of Capital Foundation (AHA/ACCF) 
guidelines (2011) recommend routine depression screening and treatment for patients with recent 
cardiovascular events. The guidelines do not well-define depression treatment in patients in order 
to reduce cardiovascular risk factors (Smith et al., 2011). The current lack of evidence, as 
reported by Coventry et al. (2014), has hindered implementation of depression treatment for 
patients with cardiovascular risk factors.  
 Psychotherapy Interventions on Cardiovascular Disease Risk Factors 
A cluster randomized control trial revealed that psychological brief therapy provided by 
primary care advanced practice nurses in collaborative care can result in reduced depression in 
patients with mental and physical comorbidities and in improvement in self-management of 
chronic disease (Coventry, P. et al., 2015; Coventry, P. A. et al., 2014). The concept of 
depression treatment prior to CVD onset has also been explored, and a randomized control trial  
showed that collaborative depression care provided prior to CVD presence reduced the risk of a 
significant CVD event in older depressed patients by half (Stewart et al., 2014). A study with 
spiritual intervention for depression concluded that there is a significant modest increase in 
overall quality of life through a 1-month intervention (Delaney, Barrere, & Helming, 2011). 
Similarly, among ethnic groups such as African Americans, a pilot study concluded that 
integrating depression treatment resulted in better outcomes among older African American 
(Bogner & Vries, 2010).  
While there are positive results from psychotherapeutic interventions, other studies have 
shown contradicting results. A cross-sectional study found that individuals had improved blood 
pressure control with or without depression treatments (Mejia-Lancheros et al., 2014). Other 
studies showed that interventions such as psychotherapy referrals and medication treatment 
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addressing CVD risk may be helpful when they are applied to both depression and 
cardiovascular disease and HbA1C, and depressive symptoms can be significantly reduced 
(Echeverry, Duran, Bonds, Lee, & Davidson, 2009; Georgiades et al., 2007). Consequently, 
studies have not found strong evidence in reduction of mortality with depression intervention 
(Whalley et al., 2014). A pilot study concluded that improved depression care after an acute 
coronary event did not improve patients behavior towards health nor their blood pressure 
(Kronish et al., 2012; see Appendix B for Synthesis of the Evidence Table). 
Theory  
 The theoretical framework that guided this project is the Collaborate Care Model (CCM), 
a version of the Chronic Care Model (Wagner, 1998). The Chronic Care Model identifies the 
problems associated with management of chronic disease in a practice; the design of this model 
was developed to provide a quality improvement framework for chronic diseases (Wagner et al., 
2001).  The CCM provides a framework for understanding of problems that can hinder quality 
care for chronic diseases (Johnston, Peppard, & Newton, 2015). The main components of CCM 
require regular interaction among collaborative team members, combined style of care among 
teams, a collaborative care plan, and complete patient participation (Johnston et al., 2015). 
Components of CCM used in this project included support from organization leadership, 
decision making by providers, evidence based research findings, and electronic databases 
(Johnston et al., 2015; see Appendix C). 
Methods 
The primary Institutional Review Board (IRB) for this project was University of Missouri 
Kansas City (see Appendix D). Site approval was obtained from project site. The EBP project 
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used electronic health records (EHR) to retrieve data but was designed to improve care instead of 
generating new knowledge; the project is considered not human subjects research. 
 Various ethnicities were included in this study including Asians, Caucasians, African 
American, and Hispanics without discrimination. The study was based in the Midwest region 
that is considered a central part of the United States. There was no exclusion criterion for 
specific cultural background; therefore, the study included all patients from different cultures. 
HIPAA regulations were followed during the collection and analysis of the data for the study 
(OCR, 2009). To ensure privacy and confidentiality, data excluded patient identification 
information, and the data was on a secured electronic drive. No student investigator research 
conflicts were present that hindered conduction of project. The only major ethical concern for the 
project included possible student investigator bias with sample selection which was avoided by 
employing random sampling.   
Funding 
 The cost for the project was expected to be minimal (see Appendix E). For 
implementation of the DNP project, meetings were held with the project directors of Quality 
Outcomes at the project sites throughout the project from March 2016-May 2017. The student 
investigator collected existing patient data from the electronic health record (EHR). The 
laboratory data and PHQ-9 screening was previously completed; therefore, the project entailed 
no extra cost to the clinic. Cost also included local travel expense for the student investigator for 
the retrieval of data from the EHR accessed at the clinic. The budget for this EBP was $280.00, 
and no cost was included for the time provided by the student investigator and the hours 
provided by team members at the project sites. Time provided by the project team was also free 
of charge as they are working to improve patient outcomes. The student investigator was 
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awarded the UMKC Women’s Council Graduate Assistance Fund and UMKC Travel Award 
Fund for funding and dissemination for this project, and the student investigator periodically 
reviewed additional costs such as printing of posters and travel expenses for dissemination which 
were covered by the funding  
Setting and Participants  
The sample for this project was patients from internal medicine clinics within the same 
system. Random sampling, computer generated, was conducted at each site. Three clinics were 
all located in the greater Midwest city area. Inclusion criteria consisted of the following: (a) adult 
patients with a diagnosis of depression as identified by the International Classification of 
Diseases (ICD), 10th revision (WHO, 2016) and ICD 9 and a PHQ-9 screening score >5; (b) 
problem list including diagnosis of diabetes with HbA1c >5, diagnosis of hypertension, and 
PHQ-9 score > 5; (c) 18 years old or older; and (d) no major psychiatric illness. The PHQ-9 was 
already a component of the electronic medical record. Exclusion criteria included patients under 
18 years of age due to clinic providing care primarily to the adult population, and patients on 
medications known to exacerbate glycemic control or blood pressure such as atypical 
antipsychotic agents. Due to anticipated participant size of greater than 30, a priori power 
calculation with GPower using t-test, 0.8 power, alpha 0.05, and medium effect of .5 revealed a 
total sample size of 34 in the project (see Appendix F for Priori Analysis). 
EBP Intervention   
The student investigator collected data during the last week of August 2016 from the 
EHR period of August 1st, 2015 to August 1st, 2016 which represented a cohort prior to 
psychotherapeutic treatment on patients who meet the inclusion criteria. This retrospective data 
and a summary of the evidence on depression and CVD was then included in a 30-minute 
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presentation at the clinics to educate providers on possible improvement in CVD risk factors 
with psychotherapeutic treatments and referrals. After the first of September 2016, 
psychotherapeutic treatments and referral was incorporated into patient care. During the first two 
weeks of January 2017, the student investigator collected existing data from September 1, 2016 – 
December 31, 2017. The data collected was identical to the baseline inclusion and exclusion 
criteria with the addition of received psychotherapeutic therapy with treatment medications for 
depression. The student investigator collected the data and placed into REDCAP, a secure 
database, and analyzed the data using SPSS (see Appendix G for timeline; Appendix H for 
Intervention).  
The analysis of data was performed during February 15, 2017-March 15, 2017, and 
several meetings (online) were held at the project sites to discuss results of the depression 
intervention. The data was presented to the providers in a 30-minute presentation in April 2017 
(see Appendix I). The content included data analysis for the depression intervention for the 
patients with cardiovascular disease risk and outcomes.  
Change Process and Evidence Based Practice (EBP) Model  
Kotter and Cohen’s model of change was utilized in this project to support the change 
process. This model proposes that the key to organizational change is helping people feel 
differently (Melnyk, 2011, p. 320). The 8-step model includes need, team selection, vision and 
strategy, communicating the vision, empowerment, provisional successes, consistent diligence, 
and nourishment (Melnyk, 2011). Kotter and Cohen’s model of change provides a framework to 
improve communication that can allow individuals to not only identify a problem but also to 
change their behavior to solve the problems (“The 8-Step Process for Leading Change,” 1996; 
see Appendix J; Appendix K for Logic Model). 
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The seven-step Iowa model was used as the model for implementing evidence based 
practice. The Iowa model focuses on organizing, collaborating, and implementing evidence 
(Doody & Doody, 2011). The steps include selecting an issue, creating a team, supporting 
evidence retrieval, rating the available evidence, developing an EBP standard, implementing 
EBP, and evaluating the outcomes (Doody & Doody, 2011). The framework functions in a cyclic 
fashion and each step presents opportunities to improve the EBP intervention. 
Sustainability 
The project had major factors promoting sustainability including the possibility of 
improved patient outcomes and minimal cost associated with the project. There was also no cost 
to the clinic staff or patients’ visit time. After completion of the project, aspects of the project 
that may result in hindrance are the time commitment for data analysis in the future from a large 
amount of data from the multiple clinics in order to verify continued benefit of the depression 
intervention.  
Study design  
This was a correlational study and provides a framework in which value of a variable is 
predicted on the data obtained from another variable or variables (Dearholt & Dang, 2012).  In 
the project, the psychotherapy interventions for depression impact on cardiovascular disease risk 
indicators of blood pressures, HbA1C, depression were explored for associations. The 
independent variable depression psychotherapy is used to predict the dependent variables of 
blood pressures, HbA1C, and depression scores.  
Validity  
The retrospective and prospective design of this evidence-based project provided a time 
efficient and inexpensive method to collect clinical data which delivered viability problems and 
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enhanced plans for future studies (Tofthagen, 2012). The EHR and databases foster internal 
validity because existing data was retrieved from information resources currently used by the 
project sites and the outcome measurement instruments were standardized across the project 
clinic and incorporated into the computerized records system. Only the student investigator 
collected the objective data which excludes patient identification information.  For external 
validity, random selection of samples from the database decreased student investigator selection 
bias and allowed for the inclusion of all ethnicities who meet inclusion and exclusion criteria. 
Confounding variables, which may affect the internal validity of the project, were patients with 
existing depression treatment with medications, poorly controlled hypertension or diabetes, and 
recent healthy lifestyle interventions of weight control including dieting and exercising. The 
project can be generalized to other populations of adults with depression at primary care clinics.  
Outcomes to be Measured  
The primary outcome to be measured was the correlation among depression, blood 
pressures and HbA1C. Additionally, measured degree of improvement of cardiovascular diseases 
risk factors of blood pressure, HbA1C, and depression PHQ-9 score after initiation of 
psychological treatment of referrals and medications for three months and the association of the 
risk factors related to depression treatment (see Appendix L; M and N).  
Measurement Instrument  
There were three main instruments for this project. For blood pressures measurement, the 
AHA guidelines and Eight Joint National Committee 8 (JNC; James et al., 2014) provided the 
essential procedure to obtain accurate and valid measurements of blood pressure (Pérgola et al., 
2007). The project sites followed AHA guidelines and JNC 8 (James et al., 2014) to gather data 
using manual sphygmomanometer. For HbA1C measurement, the American Diabetic 
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Association (ADA) guidelines provided the validity to obtain HbA1C measurements through 
laboratory testing (ADA, 2016). The PHQ-9, a United States Preventative Staff Task Force 
established tool, was used to screen for depression in adults (USPSTF, 2008). PHQ-9 scores > 10 
are reported to have a sensitivity of 88% and a specificity of 88% for Major Depressive Disorder 
(APA, 2016). The psychometric properties of the tool have been established by reliability and 
validity with internal consistency of 0.85 (Zhang et al., 2013; APA, 2016). All measurement 
instruments were in the public domain. The measurements were taken with standardized 
procedures and the project utilized the existing data. 
Quality of Data  
 Conditional regression analysis was used to determine odds ratio (OR) and a 95% 
confidence interval (CI) to evaluate depression with cardiovascular risk factors of blood 
pressures, HbA1C, and depression PHQ-9 score. A t-test was used to compare retrospective data 
collected between August 2015- August 2016 that is prior to the depression intervention and 
prospective data collected after the intervention. A paired t-test analysis was completed for data 
collected using the intervention during September 2016-December 2016. Analyses included 
collection and comparisons of blood pressures, HbA1C, and PHQ-9 scores. The study identified 
for comparison of project results to published studies was a study conducted by Lustman (1998) 
which reports effective outcomes of cardiovascular disease by improving depression with 
stepwise behavioral therapy. The study reported cognitive therapy improved glycosylated 
hemoglobin and depression which is the major risk factors for cardiovascular diseases (Lustman, 
1998).   
Analysis Plan  
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Spearman’s rank-order correlation was used to explain the correlation in outcomes within 
the intervention group. The student investigator conducted a primary analysis while using a 
scaled marginal model that tested for a total effect of the intervention over 3 month outcomes of 
blood pressure, HbA1C, depression PHQ-9 scores. A t-test was used to assess the comparison of 
outcomes within the intervention group. A paired t-test was used to compare data collected 
before and after the depression intervention. A regression analysis was also conducted to 
determine how effective independent variables are in predicting the depending variable of blood 
pressures, HbA1C, and PHQ-9 scores (see Appendix O).  
Results 
Setting & Participants  
 
 Approval for this EBP project was obtained from University of Missouri, Kansas 
City Institutional Review Board (IRB). A retrospective data set was collected from August 2015-
August 2016, which provided the framework of selected patients with required criteria. Providers 
from three internal medicine clinics were informed of an education intervention before the 
initiation of prospective data which was collected from September 2016 to January 2017. 
Randomized patients were selected according to the criterion. Initially, thirty-one patients were 
randomly selected and data was collected for pre- and post intervention (see Appendix L). The 
average age of participants was 66 years (standard deviation [SD] = 11.46). There were 17 
females and 14 males in the sample.  
Intervention Course, Actual  
 
 In phase one and two, the student investigator provided a 20-minute educational 
presentation to internal medicine clinic providers in September 2016 at the monthly provider 
meeting. The presentation included CVD and depression background, as well as significance of 
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evidence-based research on reduction of cardiovascular risk by psychotherapeutic intervention 
with pharmacotherapy. EBP objectives and implementation were explained to providers, and the 
providers were encouraged to obtain PHQ-9 scores post intervention. Furthermore, initial data  
including blood pressures, HbA1C, and PHQ-9 scores from a retrospective patient group of 
thirty-one patients was shared with the providers.   
During phase three, pre-intervention data of blood pressures, HbA1C, and PhQ-9 scores 
was obtained, and psychotherapy was initiated for patients who met criteria during September 
2016 and maintained therapy until January 2017. In phase three, total of 31 patients were seen by 
a behavioral therapist for multiple appointments as determined by the therapist. At the end of the 
four month intervention, the post intervention blood pressures, HbA1C, and PHQ-9 scores were 
obtained from the patients (see Appendix L) although post PHQ-9 scores were available for only 
four of the  participants. Phase four included analysis of the data, and in phase five, results were 
presented to providers at the internal medicine clinics at a monthly meeting in May 2017.  
Outcome Data by Sub-Topic  
 
 For analysis of the outcome, a correlation between the dependent variable PHQ-9 
and independent variables HbA1C and blood pressures was conducted using Spearman’s rank-
order correlation. Spearman’s rank-order correlation coefficient is a nonparametric measure of 
the strength and direction of associations (Runyon, 2000).  Data limitations resulted in 
correlation with post PHQ-9 scores among only four patients. However, there was a strong, 
positive correlation between post PHQ-9 and Post A1C scores which approached statistical 
significance (rs = 0.949, p = .051). To predict which variables had greater impact, a regression 
analysis (See Appendix O) revealed the unstandardized coefficient B for Post A1C, Post 
Systolic, and Post Diastolic compared to post PHQ-9 were 5.493, 0.322, and -0.938 respectively. 
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The correlation between post PHQ-9 scores and blood pressures was not statistically significant 
(Systolic, rs = 0.061, p = 0.896; Diastolic, rs = -0.09, p = 0.847). 
Also, the outcome measured was the degree of improvement of cardiovascular diseases 
risk factors of blood pressure, HbA1C, and depression PHQ-9 score after initiation of 
psychological treatment of referrals and medications for three months.   
Data for blood pressures and HbA1C was readily available, but PHQ-9 scores were not 
available for most patients post intervention. The mean values for pre- post systolic blood 
pressure were 126 (SD = 15.98) and 128 (SD = 11.95), respectively.  The mean values for pre-
post diastolic  blood pressure was 74 (SD = 9.10) and 76 (SD = 8.18), respectively. The pre 
HbA1C mean was 6.7 (SD = 1.28), and the post-HbA1C was 6.74 (SD = 1.49).  The pre-PHQ-9 
mean score was 8.2 (SD = 7.31), and the post-PHQ-9 score was 3.5 (SD = 5.83; see Appendix 
M). 
Discussion 
 
Successes, Most Important  
 
 The study question for this project posed an investigation of the correlation 
between depression and cardiovascular risk. This was explored by analyzing correlations among 
PHQ-9 scores, blood pressures, and HbA1C. Although the sample was small, the project showed 
that post PHQ-9 scores are directly correlated with post A1C scores. As depression scores 
decreased A1C scores decreased as well. This finding indicates that individuals with higher 
depression scores are more likely to have diabetes with higher HbA1Cs. This association 
increases cardiovascular disease risk for individuals with depression. The results revealed an 
increase in systolic and diastolic blood pressures, 1.27% and 2.86% respectively. There was a 
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0.09% reduction in HbA1C scores, and a major change was observed in PHQ-9 scores which 
was a 60.56% reduction using mean values of the variables. 
Regression analysis predicts that for a 5.493 score increase in PHQ-9 score there is a one 
unit increase in HbA1C scores in post score. While explicating the association between 
depression and control of cardiovascular risk factors, it is important to understand that among 
people with diabetes who also have depression that non-compliance and lack of healthy life style 
may be a common occurrence (Kimbro, Steers, Mangione, Duru, & Ettner, 2012). There is a 
cyclical pattern present between diabetes and depression (Kimbro et al., 2012).  Several studies 
have shown that major depression and diabetes are independently associated with increased 
coagulation and aggregation of platelets as well as increased response of C-reactive protein 
(Katon et al., 2004). Presence of depression with diabetes results in additional risk by behavioral 
mediators such as obesity, sedentary life style, and poor glycemic control, as well as biological 
mediators (Katon et al., 2004). The project results indicate that psychotherapy can improve 
cardiovascular risk including HbA1C.  
Although there is lack of statistical significance in this project, findings are clinically 
significant. The reduction in depression scores supports psychotherapeutic referrals. The project 
shows a correlation between post HbA1C and post PHQ- 9 scores which affirm the reduction in 
cardiovascular disease risk by psychotherapy. Studies have indicated that simultaneous treatment 
of depression in patients with diabetes in primary care setting can improve both depression and 
diabetes (Bogner & Vries, 2010).  
Study Strengths  
 
 Results of four internal medicine clinics were obtained at one of the three clinic sites by 
using the EHR. The clinics were based in urban Kansas City. The clinics were fully resourced 
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with staff to aid in successful completion of the project.  The student investigator’s site mentor, 
as well as the administrative staff, were exceptional in moving the project forward. Also, this 
project provided quality improvement information at this clinic, therefore, the success of the 
project was important to the internal medicine clinics, providers, and staff.  
 The project was expected to obtain a sample of at least thirty-four patients, but due to 
certain barriers including patient drop out and non-compliance, the project was determined to be 
a pilot study. Data was readily available for the student investigator through secure access. 
Implementation was successful initially but the post intervention data, especially post PHQ-9 
scores, was not obtained at the clinics. Psychotherapy was also an available resource for patients, 
and there was minimal wait time for patients before they visited the psychotherapist for 
behavioral intervention.   
Results Compared to Evidence in the Literature  
 
 Research is limited with the studies that focus on depression treatment, either 
psychotherapy or pharmaceutical, with cardiovascular disease risk reduction. The results of this 
project are comparable to other studies published on depression intervention for cardiovascular 
risk reduction. A study by Lustmen (1998) concluded that although there was no immediate 
changes in post intervention measures, there was a significant improvement in follow-up mean 
glycosylated hemoglobin. The result of this current project reports similar findings about 
depression and A1C correlation.  
Another study concluded that psychotherapy reduces depression and results in improved 
blood pressures for patients, and there was significant improvement observed after 8-weeks of 
psychotherapy (Ahmadpanah et al., 2016). This evidenced-based project did not show significant 
improvement in blood pressures for patients. However, results are mixed as some patients 
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showed improvement with several sessions and some did not show improvement in systolic or 
diastolic blood pressures. Additionally, some patients had improvement in blood pressures with 
only a few sessions. These findings suggest that there is a need for further research on the impact 
of psychotherapeutic and pharmacotherapeutic treatments of depression among patients at risk 
for cardiovascular disease. This is especially important to achieve the goal of decreasing 
depression among vulnerable population with multiple chronic co-morbidities.  
Limitations 
 
Internal Validity Effects  
 
Utilization of the EHR to retrieve existing data and use of standardized instruments at the 
clinic promoted internal validity of the project. Confounding variables, which could have 
affected the internal validity of the project, were patients with existing depression treatment with 
medications, poorly controlled hypertension or diabetes, recent healthy lifestyle interventions of 
weight control including diet and exercise, non-compliant patients, changes in primary care 
practices and collection of data in winter months (Rohan et al., 2013). These variables could 
have exacerbated depression results (Rohan et al., 2013).  
External validity effects  
 
For external validity, random selection of samples from the database decreased student 
investigator selection bias and allowed for the inclusion of all ethnicities that met inclusion and 
exclusion criteria. The project was expected to be generalized to other populations of adults with 
depression at primary care clinics but small sample size affected the strength of the project. The 
project was conducted over four months which is a relatively short time frame for an intervention 
to make a positive effect. Although this project focused on a population with existing chronic 
conditions and multiple co-morbidities, the depression intervention can be applied to other 
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healthier populations for the prevention of cardiovascular diseases such as hypertension and 
diabetes.  
Sustainability of effects and plans to maintain effects  
 
Internal medicine clinics were involved in this project and were working towards a policy 
change to include psychotherapeutic intervention in collaboration with pharmacotherapy. This 
project will provide strength for the depression intervention in the future as the findings indicated 
improved patient outcome. Aspects of the project that may result in hindrance of sustainability 
are the time commitment for data analysis in the future from a large amount of data from the 
multiple clinics in order to verify continued benefit of the depression intervention. There is an 
ongoing effort at the clinics to maintain the improvement in patient outcome and remind 
providers to refer patients, who have depression and at risk for cardiovascular disease, 
immediately for psychotherapy.    
Efforts to minimize the study limitations  
 
 There were several improvements that were made to minimize project limitations 
including a presentation to providers to explain the importance of the project and improved 
outcomes for patients. During the presentation to clinic staff, the importance of proper technique 
to measure blood pressure was also stressed. Biases were minimized by randomized selection. 
The effect of limitations resulted in reduced sample size which in turn provided skewed data. 
This affected the comparison of blood pressures with PHQ-9 as well as with A1C and PHQ-9. 
Interpretation 
 
Expected & Actual outcomes 
 
Expected outcomes included improved blood pressures, HbA1C, and PHQ-9 scores with 
psychotherapeutic and pharmacotherapeutic intervention and correlation among depression, 
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hypertension, and diabetes. The project showed that there is a strong correlation between PHQ-9 
scores and HbA1C values in post interventional results. Unexpected results included no 
correlation between post PHQ-9 scores and post blood pressures. Blood pressures are taken 
manually at the clinic; hence, human error is one possible reasoning for finding no correlation 
between PHQ-9 scores and blood pressures. Also, baseline blood pressures at pre intervention 
were close to normal values, therefore, there was reduced chance of improvement with 
intervention. Furthermore, PHQ-9 scores were not available for the post intervention. This is 
possibly due to educational deficit about the importance of the intervention and project. 
Although, there was a presentation prior to initiation of project to explain the importance and 
relevance of the project and possible outcomes for patients, data was not collected by the clinics.   
Intervention’s Effectiveness (Inferences)  
 
 Due to lack of post intervention PHQ-9 data, the project is now presented as a pilot study. 
However, the strong correlation between PHQ-9 scores and HbA1C scores infer that depression 
treatment greatly influences improvement in HbA1C values. Consequently, psychotherapeutic 
and pharmacotherapeutic interventions can reduce cardiovascular disease risk factors in primary 
care clinics. Causality has met all three conditions in this EBP project but cannot be implied due 
to small sample size; as the time-order is met, there is a correlation seen between PHQ-9 scores 
and HbA1C, and no other variable in the project intervention can explain this correlation. This 
project did not show any correlation between blood pressures and PHQ-9 score.  
The project intervention can be effective in any internal medicine clinic as well as family 
medicine clinic. The psychotherapy resource is the major barrier for implementation of the 
intervention as it initially increases cost to the practice. Furthermore, psychotherapist availability 
is limited for patients and sometimes require long wait before the care is available for them. As 
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long as referrals are made and patients are seen in a timely fashion, the depression intervention is 
a viable adjunct treatment option for reducing cardiovascular disease risk.     
Intervention revision  
 
 There are several changes possible for improved positive outcomes. First, the gathering 
of data prior to the intervention can be improved by obtaining blood pressures, HbA1C, and 
PHQ-9 scores at the same time to reduce possibility of skewed data. Second, intervention time 
extension can be highly valuable in explaining if more psychotherapy appointments make a 
larger impact on cardiovascular disease risk factors. Third, the project was limited to a 
population older than 50-years; it would be noteworthy to study the impact of this intervention 
on a younger population. Finally, improvement can be measured by inclusion of cholesterol 
levels because of the link with cardiovascular disease risk (Katon et al., 2004). 
Expected and actual impact to health system, costs, and policy  
 
 This evidence based intervention was shown, at least partially, to be successful in 
supporting prior evidence indicating correlation between depression and cardiovascular risks. It 
is important to keep in mind that these patients were simultaneously being treated with 
pharmacotherapy. The project provides a strong framework for change in policy and procedures 
at the primary care clinics to improve patient outcomes. The project was conducted with minimal 
cost, and the cost remained the same as predicted prior to initiation of project. Due to minimal 
cost of project, sustainability of the project is high. The primary site where the project was 
conducted already has psychotherapists employed as a team. Quality improvement teams can 
reinforce education to primary care providers about persistent referrals to a psychotherapist to 
improve cardiovascular risk factors which can easily become part of their monthly meetings, as 
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this student investigator has done. Current funding by Women’s Graduate Assistance Fund 
(GAF) provided the cost of conducting the project as well as dissemination at conferences.   
Conclusion 
 
This project explored the effect of psychological treatment and medications for 
depression in adult patients on cardiovascular disease risk factors measuring blood pressure, 
HbA1C, and depression PHQ-9 scores. This EBP initiative showed that effective treatment for 
depression can decrease the risk of cardiovascular disease in the short term. This project 
strengthens the findings of other studies and reports results that support use of both medication 
and behavioral therapy to improve outcomes for patients. However, it does not distinguish which 
therapy is superior to the other. 
The depression screening can easily be implemented with patients although referral 
services may need to be addressed by the site if services that are convenient to the patient are 
absent. Further studies should be performed to explore long-term effects of depression treatment 
in cardiovascular risk factors.  
The project results were presented at Advanced Practice Nurses of Ozarks (APNO) 
annual conference in November 2016 and Midwest Nurses Research Society’s (MNRS) annual 
conference in April 2017 as a poster presentation to educate providers and nurse researchers 
about importance of depression treatment which can ultimately foster reduction in cardiovascular 
risk factors. The providers at the project sites have data information available so that further 
evaluation or studies may be conducted. The results from this project can provide a framework 
for other studies that might have specific ethnicities or populations. Also, depression intervention 
can be separated into either psychotherapy or medications, and impacts on cardiovascular disease 
risk factors can be studied instead of the combined intervention within this project. Proper and 
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timely treatment of depression may result in decreased cardiovascular risk factors for patients as 
well as reduction in overall healthcare cost and quality of life. 
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Appendix A: Definition of Terms  
 
Prevalence - The percentage of a population that is affected with a particular disease at a given 
time. 
Psychotherapy – In respect to this project this includes pharmaceutical and behavioral 
psychological therapy for patients with depression. 
Cardiovascular disease – This term includes diseases related to cardiac function including 
hypertension, diabetes, chronic kidney disease, and cardiac anatomy change due to blood flow, 
atherosclerosis as well as other cardiac related diseases.  
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Appendix B: Synthesis of Evidence Table 
First author, Year, 
Title, Journal 
Purpose Research 
Design1 , 
Evidence 
Level2  & 
Variables 
Sample & 
Sampling, 
Setting 
Measures 
& 
Reliability 
(if 
reported) 
Results & Analysis 
Used 
Limitations & 
Usefulness 
1) Correlation between depression and cardiovascular diseases risk 
 
Seldenrijk (2015). 
Depression, anxiety 
and 6-year risk of 
cardiovascular 
disease.  Journal of 
Psychosomatic 
Research 
To examine 6-
year associations 
between 
depressive and 
anxiety disorders, 
clinical 
characteristics 
and newly-
developed CVD 
 
Quantitative, 
Level IV 
 
6 year 
incidence 
assessment 
CI 95% Cox regression 
analyses.  
Current depressive 
(but not anxiety) 
disorder 
independently 
contributed to CVD 
in our sample of 
initially CVD-free 
participants. CVD 
incidence over 
6 years of follow-up 
was particularly 
increased in subjects 
with more 
symptoms, and in 
those using 
benzodiazepines. 
 
 
Deschênesa (2015). 
Associations 
between diabetes, 
major depressive 
disorder and 
generalized anxiety 
To examine the 
associations 
between diabetes, 
disability, and the 
likelihood of 
comorbid major 
Level IV 
 
17,623 surveys CI 95% Individuals with 
diabetes may be 
particularly 
vulnerable to 
comorbid MDD and 
GAD, and MDD-
-Cross-sectional 
and thus temporal 
relationships 
between MDD, 
GAD, and 
diabetes cannot 
DEPRESSION INTERVENTIONS AND CARDIOVASCULAR DISEASE 39 
disorder 
comorbidity, and 
disability: Findings 
from the 2012 
Canadian 
Community Health 
Survey — Mental 
Health (CCHS-
MH).  Journal of 
Psychosomatic 
Research  
depressive 
disorder (MDD) 
and generalized 
anxiety disorder 
(GAD). 
GAD comorbidity 
may exacerbate 
disability in persons 
with diabetes. 
-  Composite 
International 
Diagnostic 
Interview 3.0. 
be identified. 
- Diabetes status 
was assessed via 
self-reported 
medical 
diagnoses 
 
Fiedorowicz (2014). 
Depression and 
Cardiovascular 
Disease: An Update 
on How Course of 
Illness May 
Influence Risk. Curr 
Psychiatry Rep. 
Literature review 
linking 
depressive 
disorders to 
cardiovascular 
mortality with a 
focus on how the 
course of illness 
of mood 
disorders may 
influence this risk 
Level VII 
 
N/A N/A Persons with 
depressive disorders 
and other risk 
factors for vascular 
disease represent a 
neglected, high-risk 
group for 
cardiovascular 
events. 
 
Hare (2014). 
Depression and 
cardiovascular 
disease: a clinical 
Review. European 
Heart Journal 
To explore 
relationship 
between 
depression and 
cardiovascular 
diseases. 
Level IV N/A N/A Depression is 
probably the most 
important driver of 
overall quality of 
life. 
 
 
Chang (2013). 
Cognitive 
performance in 
older elderly men 
with late-life 
Whether 
depression or 
cardiovascular 
disease would 
have a greater 
Cross 
sectional, 
Level IV 
 
207 cognitively 
impaired older 
elderly (≥75 
years old) men 
 Late life depression 
worsens 
neuropsychological 
function more than 
cardiovascular 
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depression and 
cardiovascular 
comorbidities: 
symptomatological 
correlation. Annals 
of General 
Psychiatry 
effect on 
worsening 
cognitive 
impairment in the 
burgeoning older 
elderly 
population 
comorbidities do. 
Wheeler (2012). 
Depression and 5-
year mortality in 
patients with acute 
myocardial 
infarction: Analysis 
of the IDACC 
database.  
Australian and New 
Zealand Journal of 
Psychiatry 
 
Study aimed to 
determine 
whether 
depression during 
hospitalization 
for acute MI 
(AMI) predicted 
5-year all-cause 
or cardiac 
mortality. 
Quantitative, 
RCT, Level 
IV 
 
Database of 
337 
hospitalized 
patients with 
AMI. 
CI 95% Relationship 
between mortality 
and depression 
severity is not linear 
and that the 
association only 
becomes evident 
when the severity 
reaches a threshold 
level of CES-D ≥ 
27, consistent with 
major depression. 
- SPSS statistical 
software package 
version 11.0.4 
 
Baune (2012). The 
relationship 
between subtypes of 
depression and 
cardiovascular 
disease: a 
systematic review of 
biological models.  
Translational 
Psychiatry  
Indications of 
depression 
subtype specific 
biological 
mechanisms. 
Systemic 
Literature 
review. Level 
I 
 
147 articles CI 95% Diagnostic subtypes 
rather than a 
unifying model of 
depression should 
be considered when 
investigating the 
bidirectional 
biological 
relationship between 
CVD and 
depression. 
- Studies with 
small number of 
subjects 
- Variation in 
used instruments 
and criteria to 
classify 
depression 
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Meijer (2011). 
Prognostic 
association of 
depression 
following 
myocardial 
infarction with 
mortality and 
cardiovascular 
events: a meta-
analysis of 25 years 
of research. Science 
direct 
To investigate 
changes in this 
association over 
time and to 
investigate 
subgroup effects 
between MI and 
depression. 
 
Meta analysis 
RCT, 
quantitative, 
Level I 
29 studies CI 95% Post-MI depression 
is associated with a 
1.6- to 2.7-fold 
increased risk of 
impaired outcomes 
within 24 months. 
This association 
has been relatively 
stable over the past 
25 years 
-Could not 
provide a pooled 
association that is 
consistently 
adjusted for the 
same variables 
across studies. 
(2011).  
AHA/ACCF 
Secondary 
Prevention and 
Risk Reduction 
Therapy for 
Patients With 
Coronary and 
Other 
Atherosclerotic 
Vascular Disease: 
2011 Update. AHA 
 
Evidence based 
practice 
guideline. 
Guidelines, 
Level I,  
 
 
    
American Heart 
Association - 
Professional 
Association, 
Effectiveness-based 
guidelines for the 
prevention of 
 Guidelines, 
level 1 
Studies from 
2006-2010, 
including 
randomized 
control trials 
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cardiovascular 
disease in women—
2011 update: a 
guideline from the 
American Heart 
Association. 
Vaccarino (2007).  
Depression, 
Inflammation, and 
Incident 
Cardiovascular 
Disease in Women 
With Suspected 
Coronary Ischemia: 
The National Heart, 
Lung, and Blood 
Institute-Sponsored 
WISE Study.  
Journal of the 
American College of 
Cardiology 
 
Whether the level 
of 2 
inflammatory 
biomarkers, 
interleukin-6 and 
C-reactive 
protein, 
explained the 
relationship 
between 
depression and 
CVD in 559 
women referred 
for coronary 
angiography for 
suspected 
coronary 
ischemia 
 
Quantitative, 
Randomized 
control Trials, 
Level 1 
935 
participants 
from which 
674 were used 
who filled out 
depression 
scale 
CI 95% In women with 
suspected coronary 
ischemia, 
inflammation is 
independently 
correlated with 
depression 
- Sample might 
not be 
generalized to all 
women. 
- Sample was 
heterogeneous 
- No info on 
MDD through 
interview 
- Delayed 
implementation 
of the 
psychosocial 
questionnaire 
reducing the 
sample size  
 
Van der Kooy 
(2007). Depression 
and the risk for the 
cardiovascular 
diseases: systematic 
review and meta 
analysis. 
International 
To estimate the 
risk of depression 
as an independent 
risk factor for 
various 
cardiovascular 
diseases (CVD) 
and explore the 
Quantitative, 
longitudinal 
and case 
controlled, 
Level 1 
11 studies were 
selected from a 
pool of 28 
studies  
Confidence 
interval 
95%.  
Overall combined 
risk of depression 
for the onset of 
myocardial 
infarction was 
homogenous and 
major depressive 
disorder was the 
Possibly missed 
some studies 
from non-journal 
publication. 
Presence of 
substantial 
heterogeneity 
could produce 
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Journal of geriatric 
psychiatry 
effect s of the  most important risk 
factor for 
developing CVD. 
spurious results. 
Pooling of studies 
can also be a 
limitation.  
2) Relationship between depression and cardiovascular outcomes 
Almas (2015).  
Severity of 
Depression, 
Anxious Distress 
and the Risk of 
Cardiovascular 
Disease in a 
Swedish 
Population-Based 
Cohort. PloS one. 
To determine the 
association 
between 
depression of 
varying severity 
and risk for CVD 
and to study the 
effect of 
concomitant 
anxious distress 
on this 
association. 
Quantitative, 
Cohort 
longitudinal 
study, Level I 
Mental health, 
work and 
relations 
among adults 
(20–64 years), 
with a total of 
10,443 
individuals.  
Depression and 
anxious 
distress were 
assessed using 
psychiatric 
rating scales 
and defined 
according to 
DSM-5 
CI 95% Severity level of 
depression seems to 
be of significance 
for increased risk of 
CVD among 
depressed persons.  
Higher risk of CVD 
among depressed 
individuals with 
symptoms of 
anxious distress 
 
- Low response 
rate 
- Low follow up 
rate could have 
caused potential 
underestimation 
of CVD 
outcomes.  
-  No access to 
the migration or 
death register 
Gardner-Sood 
(2015). 
Cardiovascular risk 
factors and 
metabolic 
syndrome in people 
with established 
psychotic illnesses: 
baseline data from 
the IMPaCT 
randomized 
To determine the 
prevalence of 
cardiometabolic 
risk factors and 
establish the 
proportion of 
people with 
psychosis 
meeting criteria 
for the metabolic 
syndrome (MetS) 
RCT, Cross-
sectional, 
Level I 
450 randomly 
selected out-
patients, aged 
18-65 years 
with 
established 
psychotic 
illness 
 
P<0.001 The prevalence of 
cardiometabolic risk 
factors in 
individuals with 
psychotic illnesses 
is much higher than 
that observed in 
national general 
population studies  
 
Cross-sectional 
design, and the 
lack of a control 
group 
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controlled trial.  
Psychological 
Medicine 
and to identify 
the key lifestyle 
behaviours 
associated with 
increased risk of 
the MetS and to 
investigate 
whether the MetS 
is associated with 
illness severity 
and degree of 
functional 
impairment.  
Seldenrijk (2014). 
Depression, anxiety 
and 6-year risk of 
cardiovascular 
disease.  Journal of 
Psychosomatic 
Research 
Examined 6-year 
associations 
between 
depressive and 
anxiety disorders, 
clinical 
characteristics 
and newly-
developed CVD 
Quantitative, 
Longitudinal 
study RCT, 
Level II 
 
106 subjects CI 95% Current depressive 
(but not anxiety) 
disorder 
independently 
contributed to CVD 
in our sample of 
initially CVD-free 
participants. CVD 
incidence over 6 
years of follow-up 
was particularly 
increased in subjects 
with more 
symptoms, and in 
those using 
benzodiazepines. 
Limitations:  
presence of CVD 
was not verified 
by general 
practice or 
hospitalization 
records. findings 
might have been 
affected by 
criterion 
contamination 
Mejia-Lancheros 
(2014). Blood 
pressure values and 
depression in 
To analyze 
whether 
depression may 
influence the 
Quantitative, 
Cross-
sectional 
Study, Level 
5954 
hypertensive 
patients with 
high 
CI 95% Depressive patients, 
with and without 
antidepressant 
treatment, had better 
-  Does not allow 
causal inferences 
to be drawn 
- Smaller sample 
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hypertensive 
individuals at high 
cardiovascular risk.  
BMC cardiovascular 
disorders. 
control of blood 
pressure in 
hypertensive 
individuals at 
high 
cardiovascular 
risk. 
IV 
 
cardiovascular 
risk factor from 
7447 
PREDIMED 
study 
participants 
blood pressure 
control.  
Multivariate 
analysis (logistic 
and log-linear 
regression) 
size in relation 
with depression 
- Lack of family 
history of 
depression and 
hypertension. 
 
Rude (2013). 
Depression as a 
Predictor of Length 
of Stay in Patients 
Admitted to the 
Cardiovascular 
Intensive Care Unit 
at a University 
Medical Center. 
Angiology 
 
To assess the 
impact of 
depression on 
length of stay 
(LOS) in a 
Hispanic 
population 
admitted to a 
cardiovascular 
intensive care 
unit (CVICU). 
 
Quantitative, 
Level IV 
 
151 
consecutive 
patients 
admitted to 
hospital 
 
P=0.001 Multivariate 
analysis. 
- Depression has a 
significant impact 
on LOS in a 
Hispanic population. 
Appropriate 
treatment of 
depression may 
decrease LOS and 
has the potential to 
be cost effective in 
the current health 
care environment. 
 
 
 
 
O’Neal (2012). Co-
morbid depression 
is associated with 
poor work 
outcomes in persons 
with cardiovascular 
disease (CVD): A 
large, nationally 
representative 
To examine the 
association of co-
morbid MDD 
with work 
outcomes in 
persons with and 
without CVD. 
Quantitative, 
Cross-
sectiona-
longitudinal, 
Level IV 
 
2007 
Australian 
National 
Survey of 
Mental Health 
and Wellbeing 
n=8841.  
CI 95% MDD was 
associated with a 
four-fold increase in 
impaired 
functioning.  
individuals with co-
morbid MDD and 
CVD reported 
greatest likelihood 
- Self report 
measures used, 
may have led to 
recall bias, 
misclassification 
or incorrect 
identification of 
CVD 
- Under reporting 
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survey in the 
Australian 
population. BMC 
Public Health. 
of workplace 
absenteeism.  
of MDD 
O’Neil (2011) Co-
morbid 
cardiovascular 
disease and 
depression: 
sequence of disease 
onset is linked to 
mental but not 
physical self-rated 
health. Results 
from a cross-
sectional, 
population-based 
study.  Social 
Psychiatry and 
Psychiatric 
Epidemiology 
To identify the 
prevalence of 
major depressive 
disorder (MDD) 
preceding CVD 
and secondly 
determine 
whether sequence 
of disease onset 
is associated with 
mental and 
physical self-
rated health 
Quantitative, 
Cross-
sectional, 
Level IV 
 
224 
respondents of 
the 2007 
Australian 
National 
Survey of 
Mental Health 
and Wellbeing 
(NSMHWB) 
CI 95% The proportion of 
individuals in whom 
MDD preceded 
CVD was 80.36% 
(CI: 72.57–88.15). 
One-fifth (19.64%, 
CI: 11.85–27.42) 
reported MDD onset 
at the time of, or 
following, CVD. 
MDD is most 
common prior to the 
onset of CVD. 
 
- CVD diagnosis 
self reported. 
- People with 
other circulatory 
conditions could 
have been 
included. 
 
Alderson (2011). 
How patients 
understand 
depression 
associated with 
chronic physical 
disease – a 
systematic review.  
BMC Family 
Practice. Biomed 
Central  
To understand 
people’s beliefs 
about depression, 
particularly in the 
presence of 
chronic physical 
disease 
Mixed 
method 
systematic 
review.  
Level I. 
65 studies CI 95% Approaches to 
detection of 
depression in 
physical illness need 
to be receptive to the 
range of beliefs held 
by patients. Patient 
beliefs have 
implications for 
engagement with 
depression 
screening. 
- Limit scope to 
primary care 
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(2011).  
AHA/ACCF 
Secondary 
Prevention and 
Risk Reduction 
Therapy for 
Patients With 
Coronary and 
Other 
Atherosclerotic 
Vascular Disease: 
2011 Update. AHA 
 
Update on 
evidenced-based 
practice guideline 
Level I 
  
    
3) Impact of psychotherapy interventions on reduction of cardiovascular disease risk factors 
 
Coventry (2015). 
Integrated primary 
care for patients 
with mental and 
physical 
multimorbidity: 
cluster randomised 
controlled trial of 
collaborative care 
for patients with 
depression 
comorbid with 
diabetes or 
To test the 
effectiveness of 
an integrated 
collaborative care 
model for people 
with depression 
and long term 
physical 
conditions. 
Cluster 
randomized 
controlled 
trial. Level II 
  
387 patients 
with a record 
of diabetes or 
heart disease, 
or both. 
CI 95% Collaborative care 
that incorporates 
brief low intensity 
psychological 
therapy delivered in 
partnership with 
practice nurses in 
primary care can 
reduce depression 
and improve self 
management of 
chronic disease in 
people with mental 
- Could not 
recruit and assess 
participants 
before practices 
were randomized 
- Were able to 
assess only the 
short term 
effectiveness of 
collaborative care 
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cardiovascular 
disease. BMJ 
and physical 
multimorbidity.  
Whalley (2014). 
Psychological 
Interventions for 
Coronary Heart 
Disease: Cochrane 
Systematic Review 
and Meta-analysis.  
International Journal 
of Behavioral 
Medicine 
Aims to estimate 
effects of 
psychological 
interventions on 
mortality and 
psychological 
symptoms in this 
group, updating 
an existing 
Cochrane 
Review. 
Systematic 
review and 
meta-
regression 
analyses of 
randomized 
trials. Level I. 
Sixteen studies 
(27 
publications) 
from the 2004 
Cochrane 
Review 
 
CI 95% No strong evidence 
that psychological 
intervention reduced 
total deaths, risk of 
revascularization, or 
non-fatal infarction. 
Psychological 
intervention did 
result in 
small/moderate 
improvements in 
depression and 
anxiety, and there 
was a small effect 
for cardiac 
mortality. 
 
 
-  lack of 
methodological 
detail reported by 
authors 
-  excluding our 
only Chinese 
study altered the 
inference for 
anxiety outcomes 
 
Coventry (2014). 
Characteristics of 
Effective 
Collaborative Care 
for Treatment of 
Depression: A 
Systematic Review 
and Meta-
Regression of 74 
Randomized 
Controlled Trials: 
e108114. PLoS one. 
A meta-
regression to 
identify factors in 
collaborative care 
associated with 
improvement in 
patient outcomes 
and the process 
of care. 
Randomized 
control Trials, 
Level I 
Seventy four 
trials were 
identified (85 
comparisons, 
across 21,345 
participants) 
CI 95% Trials of 
collaborative care 
that included 
psychological 
treatment, with or 
without anti-
depressant 
medication, 
appeared to improve 
depression more 
than those without 
psychological 
treatment.  
Observational 
nature of meta-
regression, 
incomplete data 
reporting, and the 
use of study 
aggregates 
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Systematic review 
with meta-
regression 
 Stewart (2013). 
Effect of 
collaborative care 
for depression on 
risk of 
cardiovascular 
events: data from 
the IMPACT 
randomized 
controlled trial.  
Psychosomatic 
Medicine 
To test 
depression 
treatment 
delivered before 
clinical CVD 
onset reduces risk 
of CVD events.  
 
Randomized 
control trial, 
Level II 
 
 235 primary 
care patients 60 
years or older 
with major 
depression or 
dysthymia in 
12-month 
collaborative 
care program. 
 
 
CI 95% Collaborative 
depression care 
delivered before 
CVD onset halved 
the excess risk of 
hard CVD events 
among older, 
depressed patients. 
 
- The IMPACT 
trial was not 
designed to test 
hypothesis of this 
project 
-  Randomization 
was not stratified 
by CVD status 
 
 
Kronish (2012). The 
effect of enhanced 
depression care on 
adherence to risk-
reducing behaviors 
after acute 
coronary 
syndromes: 
Findings from the 
COPES trial. The 
American Heart 
Journal 
Evaluates the 
impact of the 
depression 
intervention on 
health behavior 
and blood 
pressure control. 
RCT, Level II 
 
80 patients CI 95% Enhanced 
depression care after 
an ACS did not 
improve health 
behavior or blood 
pressure control 
compared to usual 
care. 
- Post hoc 
analyses 
- adherence 
behaviors were 
measured using 
single-item, 
dichotomous, 
self-report 
questions and 
thus were 
imprecise 
- self report 
 
Delaney (2011). The 
Influence of a 
Spirituality-Based 
Intervention on 
Quality of Life, 
To determine the 
feasibility and 
preliminary 
efficacy of an 
individualized 
Qualitative, 
pre-
experimental 
pilot study. 
Level IV 
Three 
community-
based 
organizations, 
(N = 27) 
N/A Patients who 
participated in the 1-
month intervention 
demonstrated a 
significant modest 
ANOVA  to 
compare the 
groups on 
demographic 
variables 
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Depression, and 
Anxiety in 
Community-
Dwelling Adults 
With 
Cardiovascular 
Disease 
A Pilot Study. 
Journal of Holistic 
Nursing 
spirituality-based 
intervention on 
health-related 
outcomes, 
depression, and 
anxiety) in 
community-
dwelling patients 
with 
cardiovascular 
disease (CVD) 
increase in overall 
quality of life. 
 
 
Bogner (2010). 
Integrating Type 2 
Diabetes Mellitus 
and Depression 
Treatment Among 
African Americans 
A Randomized 
Controlled Pilot 
Trial. The diabetic 
educator 
To examine 
whether 
integrating 
depression 
treatment into 
care for type 2 
diabetes mellitus 
among older 
African 
Americans 
improved 
medication 
adherence, 
glycemic control, 
and depression 
outcomes. 
Quantitative, 
Pilot study 
RCT, Level II 
 
58 participants 
aged 50 to 80 
years 
Not reported Integrating type 2 
diabetes mellitus 
treatment and 
depression was 
successful in 
improving outcomes 
among older African 
Americans 
 
Echeverry (2009). 
Effect of 
Pharmacological 
Treatment of 
Depression on A1C 
and Quality of Life 
To determine 
whether 
pharmacological 
treatment of 
depression in 
low-income 
Quantitative, 
RCT, level II 
150 subjects Not reported Pharmacological 
treatment of 
depression 
significantly 
improved A1C and 
systolic blood 
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1. Design: Indicate if qualitative with specific design, quantitative with specific design, SR qualitative with meta-synthesis, SR 
quantitative.   2. 1 1. 1 State the specific research design or state EBPG/guideline. 2 State the Hierarchy of Evidence per the Melnyk 7 
level.  
 
in Low-Income 
Hispanics and 
African Americans 
With Diabetes 
A randomized, 
double-blind, 
placebo-controlled 
trial. Diabetes care 
 
minorities with 
diabetes 
improves A1C 
and quality of 
life. 
pressure levels 
compared with 
placebo. 
Georgiades  (2007).  
Changes in 
Depressive 
Symptoms and 
Glycemic Control 
in Diabetes 
Mellitus.  
Psychosomatic 
Medicine. 
 
To investigate if 
changes in 
depressive 
symptoms would 
be associated 
with changes in 
glycemic control 
over a 12-month 
period in patients 
with Type 1 and 
Type 2 diabetes 
RCT, Level II 
 I don’t know 
how could 
have a 
depressive 
intervention.  
Level IV?  
90 patients Not reported Changes in 
depressive 
symptoms were not 
associated with 
changes in HbA1c 
or fasting glucose 
levels over a 1-year 
period in either 
patients with Type 1 
or Type 2 diabetes. 
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Appendix C: Theory to Application Diagram 
Adapted for DNP Project -The Collaborate Care Model (CCM)   
4 CCM components 
• Delivery system redesign 
• Self-management support 
• Clinical decision support 
• Clinical information system 
CURRENT (pre-
implementation) clinical 
and organizational 
practice patents for: 
• Managers 
• Physician/ Nurse 
Practitioners   
Implementations 
• Retrieval of data from EHR with 
HbA1c, PHQ-9 scores, Blood 
pressure 
• Analysis to show reduction of 
CVD risk factors with depression 
treatment 
• Education provided to Providers 
Early treatment 
of depression to 
reduce 
cardiovascular 
risk factors 
• DESIRED 
OUTCOME – 
Collaboration of 
primary care 
with mental 
health providers   
 Improved cardiovascular disease factors in 
measurements (Blood 
pressures, HbA1C, PHQ-9 
scores) 
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Appendix D: IRB Approval Letter 
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Appendix E: Cost Table for project 
 
Indirect Costs Amount 
APNO and MNRS Presentation cost $575.00 
Poster cost (Office Max) $25.00 
Total Indirect costs $600.00 
 
Direct Cost s Amount 
Gasoline cost to and from to Internal 
Medicine Clinic 
$2.00/gallon for 35 miles each way/trip 
10 trips 
$200.00 
Material for presentation to Providers $55.00 
Total Direct Costs  $280.00 
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Appendix F: Priori Power Analysis for Sample Size 
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Appendix G: Project Timeline 
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Appendix H: Intervention Flow Diagram  
 
 
 
 
 
DEPRESSION INTERVENTIONS AND CARDIOVASCULAR DISEASE 58 
 
Appendix I: Intervention and Educational Materials 
 
The intervention plan for the program:  Early treatment of depression to reduce 
cardiovascular risk factors (blood pressures, PHQ-9 scores, HbA1C) 
  
Phase One:  August 2016 
Presentation to providers with evidence to treat depression early resulting in reduced 
cardiovascular risk factors. 
  
Phase Two:  September 2016 
Initiation of intervention with patients treated with psychotherapy or pharmaceutical 
therapy or both.  
1. Patients will be identified by their cardiovascular risk factors with 
diagnosis of hypertension and diabetes: 
a. HbA1C > 5.5 
b. Blood Pressures (Systolic 120-130 mmHg, Diastolic 80-90 mmHg) 
c. PHQ-9 Depression severity >5 
 
Phase Three:  December 2016 – January 2017 
Completion of intervention and collection of data 
   
 
Phase four: January 2017- March 2017 
Analysis of Data 
 
Phase five: May 2017 
Data analysis presented to providers at Internal Medicine Clinic to show results of 
treatment of depression on cardiovascular risk factors.  
 
Educational Materials 
 
I used power point presentation as well as poster presentation to provide education to providers 
with importance of early treatment of depression prior to intervention. Providers are the main 
audience for the presentations. The verbal and visual power point presentation did not exceed 30 
minutes including question/answer session. The presentation was developed in accordance to 
providers’ education level with serif font (Calibri) to be easily read as well as prior approval 
from quality management team. Total of 7 providers attended the presentation session in 
September 2016.  
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Appendix J: Kotter and Cohen’s Change Model 
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Appendix K: Depression Intervention and Reduced Cardiovascular Disease Risks Logic Model 
 
Inputs  Outputs  Outcomes -- Impact  Activities Participation  Short and Long 
In order to address 
our problem we will 
conduct the 
following activities: 
 
- Retrospective data 
audit of patients with 
depression and 
cardiovascular 
disease  
- Prospective data 
after the intervention 
was also selected. 
 
 
 We expect that once 
completed or 
underway these 
activities will 
produce the 
following evidence 
of service delivery: 
 
- Intervention 
psychotherapeutic 
 
- Audit data of 
patients to observe 
change on CVD risks 
(Blood pressures, 
A1C, PHQ-9 scores) 
 
- Provide results to 
healthcare providers 
in a presentation 
- Healthcare provider 
presence at the 
presentation time. 
 - We expected that if completed or ongoing these activities will 
lead to the following changes in 3-6 months: 
 
- 5-10% reduction in systolic blood pressure 
 
- 5-10% reduction in A1C 
 
- 5-10% reduction in PHQ-9 scores 
 
 
Assumptions 
 
External Factors 
- Compliance with psychotherapy 
- Accuracy of data obtained 
- Noncompliance with psychotherapy 
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Appendix L: Data Collection Table 
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Appendix M: 
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Appendix N: Statistical Analysis Variable View 
 
 
 
  
DEPRESSION INTERVENTIONS AND CARDIOVASCULAR DISEASE 
 
64 
 
Appendix O: Regression Analysis 
 
Case Processing Summary 
 Post_A1C Post_PHQ9 
Series or Sequence Length 30 30 
Number of Missing Values in 
the Plot 
User-Missing 0 0 
System-Missing 13 23 
 
The cases are unweighted. 
 
 
Estimated Distribution Parameters 
 Post_A1C Post_PHQ9 
Normal Distribution Location 6.75 4.00 
Scale 1.540 6.557 
 
The cases are unweighted. 
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Post_A1C 
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Post_PHQ9 
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Regression 
 
Variables Entered/Removeda 
Model 
Variables 
Entered 
Variables 
Removed Method 
1 Post_A1Cb . Enter 
2 Post_Systolicb . Enter 
3 Post_Diastolicb . Enter 
 
a. Dependent Variable: Post_PHQ9 
b. All requested variables entered. 
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Model Summary 
Model R R Square 
Adjusted R 
Square 
Std. Error of the 
Estimate 
1 .948a .898 .848 3.079 
2 .956b .914 .742 4.009 
3 1.000c 1.000 . . 
 
a. Predictors: (Constant), Post_A1C 
b. Predictors: (Constant), Post_A1C, Post_Systolic 
c. Predictors: (Constant), Post_A1C, Post_Systolic, Post_Diastolic 
 
 
ANOVAa 
Model Sum of Squares df Mean Square F Sig. 
1 Regression 167.794 1 167.794 17.704 .052b 
Residual 18.956 2 9.478   
Total 186.750 3    
2 Regression 170.679 2 85.339 5.310 .293c 
Residual 16.071 1 16.071   
Total 186.750 3    
3 Regression 186.750 3 62.250 . .d 
Residual .000 0 .   
Total 186.750 3    
 
a. Dependent Variable: Post_PHQ9 
b. Predictors: (Constant), Post_A1C 
c. Predictors: (Constant), Post_A1C, Post_Systolic 
d. Predictors: (Constant), Post_A1C, Post_Systolic, Post_Diastolic 
 
 
Coefficientsa 
Model 
Unstandardized Coefficients 
Standardized 
Coefficients 
t Sig. B Std. Error Beta 
1 (Constant) -39.332 11.060  -3.556 .071 
Post_A1C 7.035 1.672 .948 4.208 .052 
2 (Constant) -47.842 24.718  -1.936 .304 
Post_A1C 6.880 2.208 .927 3.116 .198 
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Post_Systolic .073 .173 .126 .424 .745 
3 (Constant) -.359 .000  . . 
Post_A1C 5.493 .000 .740 . . 
Post_Systolic .322 .000 .554 . . 
Post_Diastolic -.938 .000 -.527 . . 
 
a. Dependent Variable: Post_PHQ9 
 
 
Excluded Variablesa 
Model Beta In t Sig. 
Partial 
Correlation 
Collinearity 
Statistics 
Tolerance 
1 Post_Systolic .126b .424 .745 .390 .972 
Post_Diastolic -.067b -.209 .869 -.205 .952 
2 Post_Diastolic -.527c . . -1.000 .310 
 
a. Dependent Variable: Post_PHQ9 
b. Predictors in the Model: (Constant), Post_A1C 
c. Predictors in the Model: (Constant), Post_A1C, Post_Systolic 
 
Regression 
 
 
Variables Entered/Removeda 
Model 
Variables 
Entered 
Variables 
Removed Method 
1 Post_A1Cb . Enter 
2 Post_Systolicb . Enter 
3 Post_Diastolicb . Enter 
 
a. Dependent Variable: Post_PHQ9 
b. All requested variables entered. 
 
 
Model Summaryd 
Model R R Square 
Adjusted R 
Square 
Std. Error of the 
Estimate Durbin-Watson 
1 .948a .898 .848 3.079  
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2 .956b .914 .742 4.009  
3 1.000c 1.000 . . .400 
 
a. Predictors: (Constant), Post_A1C 
b. Predictors: (Constant), Post_A1C, Post_Systolic 
c. Predictors: (Constant), Post_A1C, Post_Systolic, Post_Diastolic 
d. Dependent Variable: Post_PHQ9 
 
 
ANOVAa 
Model Sum of Squares df Mean Square F Sig. 
1 Regression 167.794 1 167.794 17.704 .052b 
Residual 18.956 2 9.478   
Total 186.750 3    
2 Regression 170.679 2 85.339 5.310 .293c 
Residual 16.071 1 16.071   
Total 186.750 3    
3 Regression 186.750 3 62.250 . .d 
Residual .000 0 .   
Total 186.750 3    
 
a. Dependent Variable: Post_PHQ9 
b. Predictors: (Constant), Post_A1C 
c. Predictors: (Constant), Post_A1C, Post_Systolic 
d. Predictors: (Constant), Post_A1C, Post_Systolic, Post_Diastolic 
 
Coefficientsa 
Model 
Unstandardized Coefficients 
Standardized 
Coefficients 
t Sig. B Std. Error Beta 
1 (Constant) -39.332 11.060  -3.556 .071 
Post_A1C 7.035 1.672 .948 4.208 .052 
2 (Constant) -47.842 24.718  -1.936 .304 
Post_A1C 6.880 2.208 .927 3.116 .198 
Post_Systolic .073 .173 .126 .424 .745 
3 (Constant) -.359 .000  . . 
Post_A1C 5.493 .000 .740 . . 
Post_Systolic .322 .000 .554 . . 
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Post_Diastolic -.938 .000 -.527 . . 
 
Coefficientsa 
Model 
95.0% Confidence Interval for B Collinearity Statistics 
Lower Bound Upper Bound Tolerance VIF 
1 (Constant) -86.918 8.254   
Post_A1C -.159 14.230 1.000 1.000 
2 (Constant) -361.909 266.225   
Post_A1C -21.177 34.937 .972 1.028 
Post_Systolic -2.125 2.272 .972 1.028 
3 (Constant) -.359 -.359   
Post_A1C 5.493 5.493 .697 1.434 
Post_Systolic .322 .322 .317 3.159 
Post_Diastolic -.938 -.938 .310 3.227 
 
a. Dependent Variable: Post_PHQ9 
 
 
Excluded Variablesa 
Model Beta In t Sig. 
Partial 
Correlation 
Collinearity Statistics 
Tolerance VIF 
1 Post_Systolic .126b .424 .745 .390 .972 1.028 
Post_Diastolic -.067b -.209 .869 -.205 .952 1.050 
2 Post_Diastolic -.527c . . -1.000 .310 3.227 
 
Excluded Variablesa 
Model 
Collinearity Statistics 
Minimum Tolerance 
1 Post_Systolic .972 
Post_Diastolic .952 
2 Post_Diastolic .310 
 
a. Dependent Variable: Post_PHQ9 
b. Predictors in the Model: (Constant), Post_A1C 
c. Predictors in the Model: (Constant), Post_A1C, Post_Systolic 
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Collinearity Diagnosticsa 
Model Dimension Eigenvalue Condition Index 
Variance Proportions 
(Constant) Post_A1C Post_Systolic 
1 1 1.990 1.000 .00 .00  
2 .010 14.300 1.00 1.00  
2 1 2.983 1.000 .00 .00 .00 
2 .013 15.119 .05 .95 .15 
3 .004 27.589 .95 .05 .85 
3 1 3.979 1.000 .00 .00 .00 
2 .016 15.732 .00 .62 .01 
3 .004 31.393 .15 .01 .35 
4 .000 91.792 .85 .37 .64 
 
Collinearity Diagnosticsa 
Model Dimension 
Variance Proportions 
Post_Diastolic 
1 1  
2  
2 1  
2  
3  
3 1 .00 
2 .01 
3 .00 
4 .99 
 
a. Dependent Variable: Post_PHQ9 
 
Residuals Statisticsa 
 Minimum Maximum Mean Std. Deviation N 
Predicted Value .00 15.00 6.75 7.890 4 
Residual .000 .000 .000 .000 4 
Std. Predicted Value -.856 1.046 .000 1.000 4 
Std. Residual . . . . 0 
 
a. Dependent Variable: Post_PHQ9  
 
DEPRESSION INTERVENTIONS AND CARDIOVASCULAR DISEASE 
 
74 
 
 
